Expression of the novel tumour suppressor sterile alpha motif and HD domain‐containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

Expression of the novel tumour suppressor sterile alpha motif and HD domain‐containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma

Published:2021-02-02 Issue:3 Volume:193 Page:488-496
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Xagoraris Ioanna¹,Vassilakopoulos Theodoros P.²,Drakos Elias³,Angelopoulou Maria K.²,Panitsas Fotios²^ORCID,Herold Nikolas⁴⁵,Medeiros L. Jeffrey⁶,Giakoumis Xanthoula⁷,Pangalis Gerassimos A.²⁷,Rassidakis George Z.¹⁶^ORCID

Affiliation:

1. Department of Oncology‐Pathology Karolinska Institute Stockholm Sweden

2. Department of Haematology and Bone Marrow Transplantation National and Kapodistrian University of AthensLaikon General Hospital AthensGreece

3. Department of Pathology University of Crete Medical School Heraklion Crete Greece

4. Department of Women's and Children's Health Karolinska Institute StockholmSweden

5. Theme Paediatrics Paediatric Oncology Karolinska University Hospital Stockholm Sweden

6. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston TX USA

7. Department of Haematology Athens Medical Center Psychikon Branch Athens Greece

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17352

Reference34 articles.

1. Treatment of early-stage Hodgkin lymphoma

2. Treatment of advanced-stage Hodgkin lymphoma

3. Prognostic factors in Hodgkin lymphoma

4. A Prognostic Score for Advanced Hodgkin's Disease

5. Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia;Clinical and Experimental Medicine;2024-07-13

2. SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer;Cellular Oncology;2023-09-04

3. Sticky, Adaptable, and Many‐sided: SAM protein versatility in normal and pathological hematopoietic states;BioEssays;2023-06-15

4. SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study;Frontiers in Oncology;2022-08-01

5. Genetic susceptibility to earlier ovarian ageing increases de novo mutation rate in offspring;2022-06-23